Insurer To Purdue Pharma: We Won’t Pay For OxyContin Anymore
Embattled drugmaker Purdue Pharma defends OxyContin as some insurers are dropping the drug in favor of other abuse-deterrent opioid painkillers.
The independent source for health policy research, polling, and news.
241-248 of 248 results
Embattled drugmaker Purdue Pharma defends OxyContin as some insurers are dropping the drug in favor of other abuse-deterrent opioid painkillers.
In hopes of reducing an over-reliance on pills for anxiety and pain, the Department of Veterans Affairs has taken a turn toward alternative medicine.
In Tennessee, an Obamacare consumer saw her rate go from $750 to just $5 a month. But a man in Maryland had to buy a less comprehensive plan to keep his costs under $1,000 a month. Income and geography determine prices for health insurance in the fifth year of Affordable Care Act coverage.
Open enrollment for health insurance on the Affordable Care Act exchanges started last week. Across the country, municipalities, insurers and grass-roots groups are working hard to help folks navigate the hoops.
Tennessee and Virginia regulators are considering approval of a merger between Mountain States Health Alliance and Wellmont Health System under their state laws. If they allow it, the Federal Trade Commission would be powerless to stop it.
Florida and Oklahoma counties are among the hardest hit by UnitedHealthcare's pullout from health law exchanges.
A class action lawsuit in Los Angeles and a task force in Memphis both try to counter the “adverse childhood events” that impair health and well-being.
Why is a 200-year-old icon of the medical field still in wide use in the digital age? Some say modern tools are more informative and worth the extra cost, but the stethoscope has staunch defenders.
© 2026 KFF